Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma
Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling in human non-small cell lung cancer (NSCLC) also...
Alternative Titles
Full title
Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1441866233
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1441866233
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0077459
